Folate-targeted supramolecular vesicular aggregates as a new frontier for effective anticancer treatment in in vivo model

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 1, 2012, Pages 94-102

  Paolino, Donatella ^a   Licciardi, Mariano ^b   Celia, Christian ^a   Giammona, Gaetano ^b,c   Fresta, Massimo ^a   Cavallaro, Gennara ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c National Center Research of Palermo   (Italy)

Author keywords

Colloidal drug carriers; Gemcitabine; In vivo anticancer activity; Supramolecular vesicular aggregates

Indexed keywords

COPOLYMER; FOLIC ACID; GEMCITABINE; LIPOSOME; SUPRAMOLECULAR VESICULAR AGGREGATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER THERAPY; CELL STRAIN MCF 7; CONJUGATION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TARGETING; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR REGRESSION; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; DEOXYCYTIDINE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FOLIC ACID; HUMANS; HYDRAZINES; LIPOSOMES; MCF-7 CELLS; MICE; MICE, INBRED NOD; MICE, SCID; NYLONS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866035643     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.06.001     Document Type: Article

References (37)

1. K. Letchford, and H. Burt A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes Eur. J. Pharm. Biopharm. 65 2007 259 269
2. J.P. Xu, J. Ji, W.D. Chen, and J.C. Shen Novel biomimetic polymersomes as polymer therapeutics for drug delivery J. Control. Release 107 2005 502 512
3. D.E. Discher, and F. Ahmed Polymersomes Annu. Rev. Biomed. Eng. 8 2006 323 341
4. F. Ahmed, R.I. Pakunlu, A. Brannan, F. Bates, T. Minko, and D.E. Discher Biodegradable polymersomes loaded with both paclitaxel and doxorubicin permeate and shrink tumors, inducing apoptosis in proportion to accumulated drug J. Control. Release 116 2006 150 158
5. T. Higashi, F. Hirayama, S. Misumi, H. Arima, and K. Uekama Design and evaluation of polypseudorotaxanes of pegylated insulin with cyclodextrins as sustained release system Biomaterials 29 2008 3866 3871
6. N.P. Gabrielson, and J. Cheng Multiplexed supramolecular self-assembly for non-viral gene delivery Biomaterials 31 2010 9117 9127
7. X. Zhou, W. Kong, and J.C. Shen The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine Biomaterials 29 2008 111 117
8. R.N. Shah, N.A. Shah, M.M. Del Rosario Lim, C. Hsieh, G. Nuber, and S.I. Stupp Supramolecular design of self-assembling nanofibers for cartilage regeneration Proc. Natl. Acad. Sci. USA 107 2010 3293 3298
9. D. Paolino, D. Cosco, M. Licciardi, G. Giammona, M. Fresta, and G. Cavallaro Polyaspartylhydrazide copolymer-based supramolecular vesicular aggregates as delivery devices for anticancer drugs Biomacromolecules 9 2008 1117 1130
10. M. Licciardi, D. Paolino, C. Celia, G. Giammona, G. Cavallaro, and M. Fresta Folate-targeted supramolecular vesicular aggregates based on polyaspartyl-hydrazide copolymers for the selective delivery of antitumoral drugs Biomaterials 31 2010 7340 7354
11. P.S. Low, and S.A. Kularatne Folate-targeted therapeutic and imaging agents for cancer Curr. Opin. Chem. Biol. 13 3 2009 256 262
12. R. Kolhatkar, A. Lote, and H. Khambati Active tumor targeting of nanomaterials using folic acid, transferrin and integrin receptors Curr. Drug. Discov. Technol. 8 3 2011 197 206
13. S.D. Weitman, A.G. Weinberg, L.R. Coney, V.R. Zurawski, D.S. Jennings, and B.A. Kamen Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis Cancer Res. 52 23 1992 6708 6711
14. S.D. Weitman, R.H. Lark, L.R. Coney, D.W. Fort, V. Frasca, V.R. Zurawski Jr, and B.A. Kamen Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues Cancer Res. 52 12 1992 3396 3401
15. C.P. Leamon, J.A. Reddy, M. Vetzel, R. Dorton, E. Westrick, N. Parker, Y. Wang, and I. Vlahov Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue Cancer Res. 68 23 2008 9839 9844
16. A.C. Antony Folate receptors: reflections on a personal odyssey and a perspective on unfolding truth Adv. Drug Deliv. Rev. 56 8 2004 1059 1066
17. G.T. Clifton, A.K. Sears, K.S. Clive, J.P. Holmes, E.A. Mittendorf, C.G. Ioannides, S. Ponniah, and G.E. Peoples Folate receptor α: a storied past and promising future in immunotherapy Hum Vaccin. 7 2 2011 183 190
18. A. Fritze, F. Hens, A. Kimpfler, R. Schubert, and R. Peschka-Süss Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient Biochim. Biophys. Acta 1758 2006 1633 1640
19. D. Paolino, D. Cosco, L. Racanicchi, E. Trapasso, C. Celia, M. Iannone, E. Puxeddu, G. Costante, S. Filetti, D. Russo, and M. Fresta Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity J. Control. Release 144 2010 144 150
20. A. Gabizon, D.C. Price, J. Huberty, R.S. Bresalier, and D. Papahadjopoulos Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies Cancer Res. 50 1990 6371 6378
21. A.A. Dementiev, A.A. Baikov, V.V. Ptushenko, G.B. Khomutov, and A.N. Tikhonov Biological and polymeric self-assembled hybrid systems: structure and properties of thylakoid/polyelectrolyte complexes Biochim. Biophys. Acta 1712 2005 9 16
22. M. Celano, M.G. Calcagno, S. Bulotta, D. Paolino, F. Arturi, D.A. Rotiroti, S. Filetti, M. Fresta, and D. Russo Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells BMC Cancer 4 2004 63
23. D.C. Drummond, O. Meyer, K. Hong, D.B. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol Rev. 51 1999 691 743
24. M.J. Parr, S.M. Ansell, L.S. Choi, and P.R. Cullis Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles Biochim. Biophys. Acta 1195 1994 21 30
25. M. Fresta, M. Ricci, C. Rossi, P.M. Furneri, and G. Puglisi Antimicrobial nonapeptide leucinostatin A-dependent effects on the physical properties of phospholipid model membranes J. Colloid. Interface Sci. 226 2000 222 230
26. C. Celia, M.G. Calcagno, D. Paolino, S. Bulotta, C.A. Ventura, D. Russo, and M. Fresta Improved in vitro anti-tumoral activity, intracellular uptake and apoptotic induction of gemcitabine-loaded pegylated unilamellar liposomes J. Nanosci. Nanotechnol. 8 2008 2102 2113
27. D. Cosco, A. Bulotta, M. Ventura, C. Celia, T. Calimeri, G. Perri, D. Paolino, N. Costa, P. Neri, P. Tagliaferri, P. Tassone, and M. Fresta In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer Cancer Chemother. Pharmacol. 64 2009 1009 1020
28. R. Moog, A.M. Burger, M. Brandl, J. Schuler, R. Schubert, C. Unger, H.H. Fiebig, and U. Massing Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels Cancer Chemother. Pharmacol. 49 2002 356 366
29. R. Soloman, and A.A. Gabizon Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin Clin. Lymphoma Myeloma 8 2008 21 32
30. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, H. Shmeeda, and S. Zalipsky In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice Clin. Cancer Res. 9 2003 6551 6559
31. S. Maillard, T. Ameller, J. Gauduchon, A. Gougelet, F. Gouilleux, P. Legrand, V. Marsaud, E. Fattal, B. Sola, and J.M. Renoir Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma J. Steroid Biochem. Mol. Biol. 94 2005 111 121
32. P. Van de Velde Exploration of the therapeutic potential of the antiestrogen RU 58668 in breast cancer treatment Ann. NY Acad. Sci. 761 1995 164 175
33. G. Storm, M.T. Ten Kate, P.K. Working, and I.A. Bakker-Woudenberg Doxorubicin entrapped in sterically stabilized liposomes: effects on bacterial blood clearance capacity of the mononuclear phagocyte system Clin. Cancer Res. 4 1998 111 115
34. Y.F. Hui, and J. Reitz Gemcitabine: a cytidine analogue active against solid tumors Am. J. Health Syst. Pharm. 54 1997 162 170
35. M.O. Oyewumi, R.A. Yoke, M. Jay, T. Coakley, and R.J. Mumper Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice J. Control. Release 95 2004 613 626
36. A. Gabizon, H. Shmeeda, A.T. Horowitz, and S. Zalipsky Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates Adv. Drug Deliv. Rev. 56 2004 1177 1192
37. X.B. Xiong, Y. Huang, W.L. Lu, X. Zhang, H. Zhang, T. Nagai, and Q. Zhang Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic J. Control. Release 107 2005 262 275